- LB Pharmaceuticals LBRX-- (LBRX) shared preclinical data supporting LB-102's "bimodal" mechanism at the ECNP Congress, ...
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for ...
Teva Pharmaceuticals Industries shares rose after the company's Teva Pharmaceutical affiliate said the Food and Drug Administration has approved Weltruza for extended-release injectable suspension for ...
Recently published Schizophrenia Market Insights report includes a comprehensive understanding of current treatment practices, emerging schizophrenia drugs, market share of individual therapies, and ...
AmyriAD Therapeutics B.V. ("AmyriAD"), a clinical-stage biopharmaceutical company focused on cognition in central nervous system disorders, today announced the acquisition of Recognify Life Sciences, ...
Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd, announces that it has filed amended and restated unaudited condensed interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results